Trials / Conditions / Major Depressive Disorders

Major Depressive Disorders

14 registered clinical trials studyying Major Depressive Disorders.

Status	Trial	Sponsor	Phase
Completed	Effects of Electroacupuncture on Cognitive Symptoms in Major Depressive Disorder NCT06239740	Thammasat University	N/A
Completed	The Effects of Transcranial Magnetic Stimulation on Retina and Choroidal Structures NCT06615804	Gulhane Training and Research Hospital	N/A
Unknown	Efficacy of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Major Depressive Disorder NCT04497493	Tianjin Anding Hospital	N/A
Unknown	Relapse Predicting Model for First Episode Depression NCT02942251	Shanghai Mental Health Center	N/A
Completed	Loneliness and Occurrence of Suicide Attempts and Suicidal Ideas NCT02829671	University Hospital, Montpellier	N/A
Unknown	MetAbolism vaRiability of VEnLafaxine NCT02590185	Assistance Publique - Hôpitaux de Paris	N/A
Unknown	Multi-center Imaging Genetics Studies in China NCT02681822	Tianjin Medical University General Hospital	—
Unknown	N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders NCT02972398	Tianjin Anding Hospital	N/A
Completed	Blended Depression Therapy: Cognitive Behaviour Therapy Face-to-face and Via Internet NCT02449447	Linkoeping University	N/A
Completed	Health Care Management for the Elderly in Community Through Screening NCT01347138	National Clinical Research Coordination Center, Seoul, Korea	N/A
Completed	The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours NCT01377896	AstraZeneca	—
Completed	Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder NCT00855530	Sanofi	Phase 3
Completed	Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine NCT00825058	Sanofi	Phase 3
Completed	Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine NCT00825019	Sanofi	Phase 3